BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36739425)

  • 1. Endothelial Toll-like receptor 4 is required for microglia activation in the murine retina after systemic lipopolysaccharide exposure.
    Tsioti I; Steiner BL; Escher P; Zinkernagel MS; Benz PM; Kokona D
    J Neuroinflammation; 2023 Feb; 20(1):25. PubMed ID: 36739425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia.
    Halder SK; Matsunaga H; Ishii KJ; Akira S; Miyake K; Ueda H
    J Neurochem; 2013 Jul; 126(2):243-60. PubMed ID: 23574143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation.
    Kokona D; Ebneter A; Escher P; Zinkernagel MS
    J Neuroinflammation; 2018 Dec; 15(1):340. PubMed ID: 30541565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat diet induces toll-like receptor 4-dependent macrophage/microglial cell activation and retinal impairment.
    Lee JJ; Wang PW; Yang IH; Huang HM; Chang CS; Wu CL; Chuang JH
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3041-50. PubMed ID: 26024088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
    Go M; Kou J; Lim JE; Yang J; Fukuchi KI
    Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroretinal-Derived Caveolin-1 Promotes Endotoxin-Induced Inflammation in the Murine Retina.
    Gurley JM; Gmyrek GB; McClellan ME; Hargis EA; Hauck SM; Dozmorov MG; Wren JD; Carr DJJ; Elliott MH
    Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):19. PubMed ID: 33079993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice.
    Vagaja NN; Binz N; McLenachan S; Rakoczy EP; McMenamin PG
    Br J Ophthalmol; 2013 Oct; 97(10):1343-50. PubMed ID: 23913246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.
    Chen Z; Jalabi W; Shpargel KB; Farabaugh KT; Dutta R; Yin X; Kidd GJ; Bergmann CC; Stohlman SA; Trapp BD
    J Neurosci; 2012 Aug; 32(34):11706-15. PubMed ID: 22915113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide.
    Zhou H; Lapointe BM; Clark SR; Zbytnuik L; Kubes P
    J Immunol; 2006 Dec; 177(11):8103-10. PubMed ID: 17114485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Lipopolysaccharide Exposure Exacerbates Choroidal Neovascularization in Mice.
    Tsioti I; Steiner BL; Escher P; Zinkernagel MS; Benz PM; Kokona D
    Ocul Immunol Inflamm; 2024 Jan; 32(1):19-30. PubMed ID: 36441988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation.
    Qin L; Li G; Qian X; Liu Y; Wu X; Liu B; Hong JS; Block ML
    Glia; 2005 Oct; 52(1):78-84. PubMed ID: 15920727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL/6 mice.
    Zhang J; Yu C; Zhang X; Chen H; Dong J; Lu W; Song Z; Zhou W
    J Neuroinflammation; 2018 Feb; 15(1):37. PubMed ID: 29426327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina.
    Halder SK; Matsunaga H; Ishii KJ; Ueda H
    J Neurochem; 2015 Dec; 135(6):1161-77. PubMed ID: 26364961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages.
    Kang S; Lee SP; Kim KE; Kim HZ; Mémet S; Koh GY
    Blood; 2009 Mar; 113(11):2605-13. PubMed ID: 19098273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
    Zhao W; Ma G; Chen X
    Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial immune activation programmes cell-fate decisions and angiogenesis by inducing angiogenesis regulator DLL4 through TLR4-ERK-FOXC2 signalling.
    Xia S; Menden HL; Korfhagen TR; Kume T; Sampath V
    J Physiol; 2018 Apr; 596(8):1397-1417. PubMed ID: 29380370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM17-Mediated Ectodomain Shedding of Toll-Like Receptor 4 as a Negative Feedback Regulation in Lipopolysaccharide-Activated Aortic Endothelial Cells.
    Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
    Cell Physiol Biochem; 2018; 45(5):1851-1862. PubMed ID: 29510400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia.
    Lee JW; Nam H; Kim LE; Jeon Y; Min H; Ha S; Lee Y; Kim SY; Lee SJ; Kim EK; Yu SW
    Autophagy; 2019 May; 15(5):753-770. PubMed ID: 30523761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.
    Parajuli B; Sonobe Y; Kawanokuchi J; Doi Y; Noda M; Takeuchi H; Mizuno T; Suzumura A
    J Neuroinflammation; 2012 Dec; 9():268. PubMed ID: 23234315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling.
    Wu Y; Wang Y; Gong S; Tang J; Zhang J; Li F; Yu B; Zhang Y; Kou J
    Biomed Pharmacother; 2020 May; 125():109868. PubMed ID: 32036210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.